1. Sharma RA, Farmer PB (2004) Biological relevance of adduct detection to the chemoprevention of cancer. Clin Cancer Res 10(15):4901–4912
2. Leykum LK, El-Serag HB, Cornell J, Papadopoulos KP (2007) Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. Clin Gastroenterol Hepatol 5(4):508–512
3. Poduri CD (2003) Hepatitis C virus (HCV) – a review; molecular biology of the virus, immunodiagnostics, genomic heterogeneity and the role of virus in hepatocellular carcinoma. Indian J Exp Biol 41(6):549–562
4. Hara A, Sakata K, Yamada Y, Kuno T, Kitaori N, Oyama T, Hirose Y, Murakami A, Tanaka T, Mori H (2005) Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N, N-diethylnitrosamine-induced hepatocellular carcinomas in rats. Oncol Rep 14(2):345–351
5. Sakata K, Hara A, Hirose Y, Yamada Y, Kuno T, Katayama M, Yoshida K, Zheng Q, Murakami A, Ohigashi H, Ikemoto K, Koshimizu K, Tanaka T, Mori H (2004) Dietary supplementation of the citrus antioxidant auraptene inhibits N, N-diethylnitrosamine-induced rat hepatocarcinogenesis. Oncology 6(3):244–252